The aim of this investigation was to compare the effectiveness of Bova deslorelin and chorolon to effect ovulation within 48 hrs of administration. Secondly, the aim was to evaluate the effectiveness of deslorelin and chorolon on mares with suspected antibodies to hCG.
Discover the efficacy of ovulation induction treatments in mares. Bova-supported study compares hCG, deslorelin, and more.
Attendees will be cognizant of the following information by the end of the webinar:
• Horses that graze can be infected by the tapeworm, Anoplocephala perfoliata
•Equine tapeworm has an indirect lifecycle involving an oribatid/pasture mite intermediate host
• Adult tapeworms are hermaphrodite and intermittently release segments containing eggs
• The adult worms are found in caecum and, particularly, the ileo-caeco-colic junction
•Most horses have low burdens of tapeworm
• The prevalence of tapeworm varies between different groups of horses
• A main risk factor for tapeworm infection is access to pasture• Horses are infected year-round with tapeworm
• Equine tapeworm can cause colic
• The level of burden correlates with the risk of colic
• Burdens of 20 tapeworms and over have been demonstrated as pathogenic
• Serum IgG(T) levels to tapeworm excretory/secretory (ES) antigens of 12/13 kDa correlate with infection intensity
• Serum IgG(T) to 12/13 kDa ES antigens correlates with risk of colic
• Anthelmintic resistance in tapeworm to praziquantel and pyrantel was reported in 2023
• Faecal egg count tests have poor sensitivity for detecting tapeworm infection due to intermittent release of egg-containing proglottids and burdens comprising a proportion immature/sterile worms
• Serum and saliva tests that measure IgG(T) to tapeworm 12/13 kDa ES antigens can be used to diagnose infection to inform anthelmintic treatments and as an aid to diagnosis in colic cases
• Horses can be assessed in theTapeworm Blood Test 4 months after their last treatment
• Horses can be assessed in the EquiSal Tapeworm Saliva Test 3 months after their last treatment • Tapeworm antibody tests do not provide a value for exact numbers of worms but generate a score that provides a low, borderline or moderate/high tapeworm diagnosis. Treatment is recommended for horses that report a result as borderline or moderate/high
• Use of the EquiSal Tapeworm Saliva Test has led to considerable reductions in anti-tapeworm treatments in the UK, with 2 out of 3 horses tested not requiring treatment based on test results
• Control of tapeworm should combine good pasture management (low stocking density, removal of dung at least twice a week) with diagnostic testing to inform treatment decisions
• Anthelmintics licensed to treat equine tapeworm in the UK are pyrantel embonate (at twice the dose used for nematode species) and praziquantel (in combination with a macrocyclic lactone or as a single-active extemporaneous formulation that can only be prescribed by a veterinary surgeon).
The Equine Medical Urology and Nephrology webinar in 2024 is led by Dr. Francois-Rene Bertin where he will focus on diagnosis, treatment, and management of various renal diseases including urinary tract disorders. Dr. Bertin, an expert in equine endocrinology, is an associate professor and the research director at the University of Queensland.
The Equine Hepatic Disorders (2023) is a series exploring clinical and metabolic causes of liver disease in horses. It’s led by Dr. François-René Bertin, an authority in equine endocrinology from The University of Queensland. He is known for co-authoring research articles, book chapters and a leading textbook on equine endocrinopathies.
Delve into the intricacies of equine foaling, emphasising the critical need for early detection and intervention in challenging birthing situations. Beginning with a comprehensive overview of the normal foaling process, and signs indicative of a healthy foaling.An overview of difficult birth events, outlining causes and risk factors associated with dystocia. The crucial aspect of detecting these challenges is addressed through the examination of behavioural cues & physical indicators. Emergency preparedness, practical insights and intervention strategies. This presentation underscores the importance of proactive management, continuous learning, and vigilant care in equine breeding and foaling practices.
In this webinar, James Crabtree of Equine Reproductive Services (UK) Limited discusses the use of antimicrobials in the treatment of bacterial placentitis. James will provide a brief overview of the pathophysiology of placentitis and will discuss the use of the prescribing cascade in the face of treating mares during pregnancy, the discussion will then be focussed specifically onantimicrobials with the choice and dose of antibiotics used and the likely duration of antibiotic therapy. The potential role for local antibiotic therapy will be discussed.
Antibiotic resistance is one of the most serious public health threats we face today. In equine practice, limited antibiotic options increase pressure to use critically important agents. With growing awareness around antimicrobial stewardship, it’s vital to understand when, why, and how much we’re using.
Join our upcoming webinar to explore antibiotic use in horses, with a focus on perioperative protocols and total antibiotic consumption in equine settings. We’ll also discuss cefazolin—an older antibiotic recently reintroduced, offering a safer alternative for stewardship compared to ceftiofur or enrofloxacin.
Let’s make informed choices and protect both animal and human health.
📅 Register now to secure your place.
